PUBLISHER: Grand View Research | PRODUCT CODE: 2189377
PUBLISHER: Grand View Research | PRODUCT CODE: 2189377
The global RNA editing market size was valued at USD 157.9 million in 2025 and is projected to grow from USD 184.8 million in 2026 to USD 588.4 million by 2033, at a CAGR of 18.0% from 2026 to 2033. North America dominated the market, accounting for the largest revenue share of 58.0% in 2025. The market growth is driven by rising partnership and licensing activity between large pharmaceutical companies and RNA editing developers, the first clinical evidence of therapeutic RNA editing in humans, and growing interest in reversible editing approaches that correct disease-causing mutations at the RNA level without permanently changing the genome.
Global RNA Editing Market Report Segmentation
This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global RNA editing market report based on offering, technology, delivery modality, application, end use, and region: